HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MoCRA Check-In: Tick, Tock, Tick, Tock…

Executive Summary

The compliance clock is ticking! A breakdown of key requirements under new cosmetics regulations and related developments in recent weeks.

You may also be interested in...

FDA Has Early Holiday Gift For Cosmetics Industry: More Time To Register Under MoCRA

The US Food and Drug Administration will delay enforcement of the first registration deadline for cosmetic facility manufacturers and cosmetic product listings under the Modernization of Cosmetics Regulation Act until 1 July, 2024.

Information Deluge Headed US FDA’s Way When Cosmetics Registration Portal Opens

In comments on FDA draft guidance released in August, industry members raise questions about the agency’s capacity to deal with an anticipated flood of facility registrations and product listings. Confidentiality and international trade also figure among concerns.

SafetyCall On What Cosmetics Companies Need In Their AE Reporting Systems

Companies preparing for adverse event reporting and recordkeeping deadlines on 29 December under new cosmetics regulations should ensure they have systems in place for netting complaints across media, triaging reports, and making speedy weight-of-evidence determinations, said SafetyCall International’s Rick Kingston at IBA’s recent FDA regulatory workshop.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts